Latest News & Updates
Breaking News
6 hours ago
Simantini Singh Deo
Other trending news you may like to read
Cassava Sciences, Inc. Rebrands As Filana Therapeutics, Inc. To Focus On Filamin A-Based Therapies For CNS Disorders
Cassava Sciences, Inc. rebrands as Filana Therapeutics, Inc. to advance filamin A-targeted therapies for CNS disorders.
Simantini Singh Deo
Celularity Inc. Enters Strategic Commercialization Partnership To Monetize Placental-Derived Biomaterials Portfolio
Celularity Inc. signs commercialization deal to monetize its placental-derived biomaterials portfolio.
Simantini Singh Deo
MBX Biosciences, Inc. Appoints Karen Basbaum As Chief Business Officer To Strengthen Strategic Growth Efforts
MBX Biosciences, Inc. appoints Karen Basbaum as Chief Business Officer to drive partnerships and strategic growth.
Simantini Singh Deo
Oragenics, Inc. Receives Final HREC Approval In Australia To Begin Phase IIa Trial Of ONP-002 For Concussion Treatment
Oragenics, Inc. receives Australian HREC approval to begin Phase IIa trial of ONP-002 for concussion treatment.
Simantini Singh Deo
